MedTrace Logo

iCare for Cancer Patients

NCT02435550 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2019-12-20

No results posted yet for this study

Summary

The purpose of this study is to use genomic information from individual patients to create simulation avatars that will be used to predict novel drug combinations with therapeutic potential.

Conditions

Interventions

GENETIC

Molecular diagnostic testing

Molecular diagnostic testing will be performed on peripheral blood, bone marrow aspirate and saliva samples that will be collected from each patient as part of routine care. Tests performed may include: cytogenetics, FISH, chromosome copy number variation, next generation DNA sequencing, methylation, and metabolomics.

Sponsors & Collaborators

  • Cellworks Group Inc.

    collaborator INDUSTRY

  • Gateway for Cancer Research

    collaborator OTHER

  • University of Florida

    lead OTHER

Principal Investigators

  • Christopher R. Cogle, MD · University of Florida

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-26
Primary Completion
2019-10-01
Completion
2019-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02435550 on ClinicalTrials.gov